ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664W905. A total of 6 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $223 | -27.4% | 227,900 | +3.2% | 0.00% | – |
| Q2 2023 | $307 | -31.0% | 220,900 | -21.2% | 0.00% | – |
| Q1 2023 | $445 | -92.1% | 280,400 | -68.9% | 0.00% | -100.0% |
| Q4 2022 | $5,612 | -99.8% | 900,900 | +161.0% | 0.01% | +100.0% |
| Q3 2022 | $2,312,000 | -14.7% | 345,200 | -19.0% | 0.00% | 0.0% |
| Q2 2022 | $2,709,000 | +142.1% | 426,100 | +76.7% | 0.00% | +200.0% |
| Q1 2022 | $1,119,000 | +115.2% | 241,200 | +131.9% | 0.00% | 0.0% |
| Q4 2021 | $520,000 | -74.7% | 104,000 | +8.1% | 0.00% | -50.0% |
| Q3 2021 | $2,055,000 | +1.0% | 96,200 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $2,034,000 | +225.4% | 96,200 | +43039.0% | 0.00% | +100.0% |
| Q1 2021 | $625,000 | -11.6% | 223 | -18.0% | 0.00% | 0.0% |
| Q4 2020 | $707,000 | +217.0% | 272 | +353.3% | 0.00% | – |
| Q3 2020 | $223,000 | -83.0% | 60 | -76.6% | 0.00% | -100.0% |
| Q2 2020 | $1,313,000 | +183.6% | 256 | +74.1% | 0.00% | +100.0% |
| Q1 2020 | $463,000 | -76.6% | 147 | -55.7% | 0.00% | -75.0% |
| Q4 2019 | $1,979,000 | +90.1% | 332 | +16.9% | 0.00% | +33.3% |
| Q3 2019 | $1,041,000 | +141.0% | 284 | +205.4% | 0.00% | +200.0% |
| Q2 2019 | $432,000 | -48.8% | 93 | -55.7% | 0.00% | -50.0% |
| Q1 2019 | $843,000 | -40.9% | 210 | -32.3% | 0.00% | -50.0% |
| Q4 2018 | $1,426,000 | +189.8% | 310 | +179.3% | 0.00% | +100.0% |
| Q3 2018 | $492,000 | -9.6% | 111 | -20.1% | 0.00% | 0.0% |
| Q2 2018 | $544,000 | +146.2% | 139 | -63.1% | 0.00% | -80.0% |
| Q1 2018 | $221,000 | -14.0% | 377 | +49.6% | 0.01% | -9.1% |
| Q4 2017 | $257,000 | +5040.0% | 252 | +769.0% | 0.01% | – |
| Q3 2017 | $5,000 | -95.2% | 29 | -71.0% | 0.00% | -100.0% |
| Q2 2017 | $104,000 | -57.2% | 100 | -74.4% | 0.01% | -54.5% |
| Q1 2017 | $243,000 | +2109.1% | 391 | +598.2% | 0.01% | +1000.0% |
| Q4 2016 | $11,000 | -56.0% | 56 | -8.2% | 0.00% | -50.0% |
| Q3 2016 | $25,000 | – | 61 | +662.5% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 8 | -78.9% | 0.00% | – |
| Q1 2016 | $4,000 | -42.9% | 38 | -19.1% | 0.00% | -100.0% |
| Q4 2015 | $7,000 | -92.3% | 47 | -89.5% | 0.00% | -85.7% |
| Q3 2015 | $91,000 | -53.3% | 447 | +338.2% | 0.01% | -56.2% |
| Q2 2015 | $195,000 | -57.6% | 102 | -53.6% | 0.02% | -69.8% |
| Q1 2015 | $460,000 | +3438.5% | 220 | +450.0% | 0.05% | +2550.0% |
| Q4 2014 | $13,000 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 220 | $460,000 | 0.05% |
| GROUP ONE TRADING, L.P. | 10,000 | $926,000 | 0.02% |
| Citadel Advisors | 24,100 | $2,232,000 | 0.00% |